Oramed Pharmaceuticals Inc (ORMP) — Cash Flow-to-Debt Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow-to-Debt Ratio of -0.34x as of December 2025, meaning its operating cash flow of $-4.05 Million could theoretically repay 0% of its total liabilities ($12.03 Million) in one year. See ORMP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oramed Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Oramed Pharmaceuticals Inc across 22 annual periods. Also explore ORMP net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oramed Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Oramed Pharmaceuticals Inc. For market capitalisation and broader financial context, see ORMP company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.76x | $-9.14 Million | $12.03 Million | ▲ +10.3% |
| 2024 | -0.85x | $-8.41 Million | $9.93 Million | ▼ -374.4% |
| 2023 | -0.18x | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.74x | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.84x | $-21.18 Million | $11.48 Million | ▼ -74.3% |
| 2020 | -1.06x | $-12.44 Million | $11.75 Million | ▼ -24.9% |
| 2019 | -0.85x | $-12.94 Million | $15.27 Million | ▲ +5.8% |
| 2018 | -0.90x | $-14.66 Million | $16.29 Million | ▼ -200.6% |
| 2017 | -0.30x | $-5.83 Million | $19.47 Million | ▼ -207.0% |
| 2016 | 0.28x | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $1.53 Million | ▲ +19.6% |
| 2014 | -4.03x | $-4.07 Million | $1.01 Million | ▲ +37.1% |
| 2013 | -6.41x | $-3.40 Million | $529.41K | ▼ -322.7% |
| 2012 | -1.52x | $-2.30 Million | $1.52 Million | ▲ +45.2% |
| 2011 | -2.77x | $-1.67 Million | $602.02K | ▼ -21.1% |
| 2010 | -2.29x | $-1.42 Million | $620.62K | ▲ +47.7% |
| 2009 | -4.37x | $-2.25 Million | $515.66K | ▼ -117.4% |
| 2008 | -2.01x | $-1.84 Million | $913.95K | ▼ -368.4% |
| 2007 | -0.43x | $-611.00K | $1.42 Million | ▲ +27.7% |
| 2006 | -0.59x | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $10.00K | — |